Overview
Dulera is a prescription drug approved by the Food and Drug Administration (FDA) in 2010 for maintenance treatment of asthma. Dulera helps prevent bronchospasm in chronic obstructive pulmonary disease (COPD). Dulera is not indicated for rescue usage during acute bronchospasms.

Dulera is a combination drug containing both Mometasone and Formoterol. Mometasone is a glucocorticoid steroid, a drug that suppresses the immune system. Mometasone is believed to work by reducing inflammation in the lungs, lowering the risk of bronchospasm. Formoterol is a long-acting bronchodilator, a drug that dilates the bronchi and bronchioles in the lungs, making it easier to breathe. Form... read more

Dulera (Mometasone/Formoterol) Questions

MyCOPDTeam is a free social network that makes it easy to find others like you and gain insights from others living with COPD.
Sign up Log in